A rapid microarray-based method for monitoring of all currently known single nucleotide polymorphisms associated with parasite resistance to antimalaria drugs

Détails

ID Serval
serval:BIB_6C68E877E81B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
A rapid microarray-based method for monitoring of all currently known single nucleotide polymorphisms associated with parasite resistance to antimalaria drugs
Périodique
Journal of Clinical Microbiology
Auteur⸱e⸱s
Crameri  A., Marfurt  J., Mugittu  K., Maire  N., Regos  A., Coppee  J. Y., Sismeiro  O., Burki  R., Huber  E., Laubscher  D., Puijalon  O., Genton  B., Felger  I., Beck  H. P.
ISSN
0095-1137 (Print)
Statut éditorial
Publié
Date de publication
09/2007
Volume
45
Numéro
11
Pages
3685-3691
Notes
Journal article --- Old month value: Sep 5
Résumé
Parasite drug resistance is partly conferred by single nucleotide polymorphisms (SNPs) and monitoring these has been proposed as alternative to monitor drug resistance. Therefore, techniques are required facilitating analyses of multiple SNPs on epidemiological scale. We report a rapid and affordable microarray technique for application in epidemiological studies on malaria drug resistance. We have designed a multi-well microarray which is used in conjunction with PCR amplifid target genes implicated in drug resistance of malaria with subsequent one tube mini-sequencing using two fluorochromes. The drug resistance associated genes for pfdhfr, pfdhps, pfcrt, pfmdr1, and pfATPase were amplified and analysed in cultured P. falciparum strains and from field samples. We obtained a specificity of 94% compared to sequence data and comparison of field samples with RFLP typing resulted in an overall consistency of >90%, except for pfdhfr51 where most discrepancies were due to false determination in mixed infections by RFLP. The system is sufficiently sensitive to assay parasites in clinical malaria and in most asymptomatic cases and allows thus high throughput with minimal hands-on time. Cost for the assay have been calculated as 0.27 EURO/SNP (0.33 US$) which is below the cost incurred by other systems. Due to the simplicity of the approach newly identified SNPs can be incorporated rapidly. Such monitoring system makes it also possible to identify re-emergence of drug susceptible parasites once a drug has been withdrawn.
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/01/2008 12:49
Dernière modification de la notice
20/08/2019 15:26
Données d'usage